MedPath
FDA Approval

Calcium Edetate de Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
BTG International Inc
DUNS: 617382395
Effective Date
April 27, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcium Edetate de Sodium

Product Details

NDC Product Code
50633-320
Route of Administration
INTRAVENOUS
Effective Date
October 20, 2022
Code: 8U5D034955Class: ACTIBQuantity: 50 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath